MUC-17

MUC-17

MUC-17 Informations sur la molécule

Molecule Name
Mucin-17
Alias de la molécule
Mucin-17,MUC-17,MUC17,MUC-3,MUC3
Drug Development Progress
Nombre de médicaments cliniques3
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 2 Clinical
Alias de la cible
Small intestinal mucin-3,MUC-3
Contexte de la molécule
Membrane mucins have several functions in epithelial cells including cytoprotection, extravasation during metastases, maintenance of luminal structure, and signal transduction. MUC17, contains an extended, repetitive extracellular glycosylation domain and a carboxyl terminus with two EGF-like domains, a SEA module domain, a transmembrane domain, and a cytoplasmic domain with potential serine and tyrosine phosphorylation sites. Interacts via its C-terminus with PDZK1 and this interaction appears important for proper localization. Probably plays a role in maintaining homeostasis on mucosal surfaces.

MUC-17 Liste de produits

Species
  • Human(2)
Tag
  • His Tag(1)
  • His Tag & Avi Tag(1)
Host
  • HEK293(2)
Conjugate
  • Biotin-labeled(1)
  • Unconjugated(1)
Grade
  • RUO(2)
Low Endotoxin
  • No(2)
MoleculeCat. No.Product NameEspèceHostStructurePurityActivitySize&PriceAdd to Cart
MUC-17
Human MUC-17 Protein, His Tag
Human
HEK293
SDS-PAGE
ELISA

$390.00

100ug
MUC-17
Avitag
MU7-H82E3
Biotinylated Human MUC-17 Protein, His,Avitag™
Human
HEK293
SDS-PAGE

$505.00

25ug
You Have Viewed 1-2 Of 2 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
ZGGS-34ZGGS34; ZGGS-34Phase 2 ClinicalSuzhou Zelgen Biopharmaceuticals Co Ltd
Solid tumours
Details
HDM-2012HDM-2012Phase 1 ClinicalHangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Solid tumours
Details
SSS-59SSS59; SSS-59Phase 1 ClinicalShenyang Sunshine Pharmaceutical Co Ltd
Neoplasms
Details
Customer Reviews